(WTAQ-WLUK) — Kimberly-Clark shareholders have voted to approve the purchase of Tylenol maker Kenvue.
The approval marks a major step toward finalizing the $48.7 billion deal.
Kimberly-Clark says 96% of shares present at its special meeting voted to approve the acquisition. At Kenvue’s special meeting, the sale received 99% approval…